Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma".
Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, Clifton-Bligh R, Robinson B, Sywak M, Sidhu S, Chou A, Gill AJ, Glover A. Kesby N, et al. Among authors: tsang v. J Clin Endocrinol Metab. 2023 Dec 21;109(1):e437. doi: 10.1210/clinem/dgad380. J Clin Endocrinol Metab. 2023. PMID: 37379017 No abstract available.
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma.
Chou A, Qiu MR, Crayton H, Wang B, Ahadi MS, Turchini J, Clarkson A, Sioson L, Sheen A, Singh N, Clifton-Bligh RJ, Robinson BG, Gild ML, Tsang V, Leong D, Sidhu SB, Sywak M, Delbridge L, Aniss A, Wright D, Graf N, Kumar A, Rathi V, Benitez-Aguirre P, Glover AR, Gill AJ. Chou A, et al. Among authors: tsang v. Mod Pathol. 2023 Dec;36(12):100329. doi: 10.1016/j.modpat.2023.100329. Epub 2023 Sep 15. Mod Pathol. 2023. PMID: 37716505 Free article.
Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
Wu L, Carlino MS, Brown DA, Long GV, Clifton-Bligh R, Mellor R, Moore K, Sasson SC, Menzies AM, Tsang V, Gunton JE. Wu L, et al. Among authors: tsang v. J Clin Endocrinol Metab. 2024 Aug 13:dgae555. doi: 10.1210/clinem/dgae555. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39136234 No abstract available.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC.
Aredo JV, Wakelee HA, Ramchandran KJ, Neal JW, Diehn M, Hui AB, Salahudeen A, Kwong B, Berry GJ, Guo HH, Cunanan K, Vali S, Pancirer D, Tsang V, Hwang G, Loza M, Johnson B, Blanchard I, Padda SK. Aredo JV, et al. Among authors: tsang v. JTO Clin Res Rep. 2024 Oct 17;5(12):100741. doi: 10.1016/j.jtocrr.2024.100741. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39624248 Free PMC article.
590 results